/2561 November 12, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q3/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

IDH-AC-000-อส6302/30.00 20 February 2020 Re: Management Discussion and Analysis Operating results for the year ended 31 December 2019 To: President The Stock Exchange of Thailand Overview of the

No. ADD-IR2021/001 19 May 2021 Subject: Management discussion and analysis for the performance for the three-month period ended 31 March 2021 To: President The Stock Exchange of Thailand AddTech Hub

/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

increased to 14.8% when compare to the same period of 2016 which gross profit margin was 11.73%. Due to price of the raw material in stock was lower than the average market price. 3. Selling expenses was Baht

Microsoft Word - MD&A 2017 EN.doc EFORL IR010/2018 March 20, 2018 Subject: Management Discussion and Analysis Yearly Ending 31 December, 2017 To President The Stock Exchange of Thailand 1. Overview

[COMPANY NAME] EFORL IR010/2018 March 20, 2018 Subject: Management Discussion and Analysis Yearly Ending 31 December, 2017 To President The Stock Exchange of Thailand 1. Overview financial

- Translation - 11 August 2017 Subject: Management’s Discussion and Analysis for the Operating Results of the Second Quarter of 2017 Attention: The President of the Stock Exchange of Thailand Exotic

repayment of short- term borrowings from financial institutions by using money gained from trading of its ordinary shares in the MAI stock exchange. • Other current assets decreased by Baht 35.06 million

/2018 February 15 , 2018 Re: Management Discussion and Analysis (MD&A) For Year 2017 Attn: President The Stock Exchange of Thailand Baan Rock Garden Public Company Limited wishes to clarify the Company’s